J&J on the move, new Antibiotic approved

Started by Epic
This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
Get help with your application

Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.

Advertisement - Members don't see this ad
You wouldn't happen to be one of those people that rolls their eyes and mocks the other people while their talking would you? 🙄

only if they're stupid and i want them to know I think they're stupid..
 
Advertisement - Members don't see this ad
YES! He called me the clinical god!!!! oh ..she.
You had better count your lucky stars. My pathophys professor has made my existence in pharmacy school a little easier. He keeps cracking jokes that are actually entertaining, unlike some people :meanie:.

I gotta head back to class.
 
You had better count your lucky stars. My pathophys professor has made my existence in pharmacy school a little easier. He keeps cracking jokes that are actually entertaining, unlike so people :meanie:.

I gotta head back to class.

I really am entertaining... my 2 year old boy seems to think so..
 
Doesn't everyone do this??? Don't forget the beauty of the mute button!! (Although my boss said once, "these meetings are a colossal waste of my time." and didn't have himself muted... Oops!) :laugh:

Your boss is somebody I would roll my eyes at..
 
🙄 LOL!!! So do I, almost daily! But, he's great. He tries to be funny, and sometimes he even succeeds. He tells funny stories, so I think that's why we get along, mostly.

hmmm.... hey..do you work for me by any chance??
 
Advertisement - Members don't see this ad
So did that press release say you can use this as a SINGLE agent for Pseudomonas? I could see that as a big advantage.
 
So did that press release say you can use this as a SINGLE agent for Pseudomonas? I could see that as a big advantage.

conventional wisdom says dual coverage is desired for pseudomonas..but there are conflicting studies.. not for Doripenem..but generally speaking.

I can't imagine how Dori would be much different than Mero or Imi as far as pseudomona coverage goes. It really depends on your local sensitivity...
 
conventional wisdom says dual coverage is desired for pseudomonas..but there are conflicting studies.. not for Doripenem..but generally speaking.

I can't imagine how Dori would be much different than Mero or Imi as far as pseudomona coverage goes. It really depends on your local sensitivity...

So really what's the advantage? It's basically just a new drug that'll be overused until resistance emerges.
 
why would it be overused if it's not on the formulary..

Haha I guess that's the key and you'll be keeping it off. Well if it's no different than the others then it really wouldn't need to be added. Either way it's another drug in the arsenal...can't really hurt for it to be waiting in the wings while the others are being used.
 
Haha I guess that's the key and you'll be keeping it off. Well if it's no different than the others then it really wouldn't need to be added. Either way it's another drug in the arsenal...can't really hurt for it to be waiting in the wings while the others are being used.

But would you think Johnson & Johnson: Ortho McNeil investing hundreds of million dollars to just let the drug sit in the arsenal waiting to be used? The miniskirts will get shorter, heels will get taller, reps will get younger and lunches will get tastier.. and the drug will get promoted like there is no tomorrow. And the cost of healthcare at our expense will again rise.
 
Who is using a carbapenem as empiric therapy against Pseudomonas?

Did you not read Dec 21 issue of NEJM Cefotetan vs Ertapenem in colorectal surgery prophylaxis? Not pseudomonas related...more B-fragilis.. but Merck reps are out in full force pushing it for CRS prophylaxis...imagine..carbapenem for surgical prophylaxis. Stop the madness.
 
Who is using a carbapenem as empiric therapy against Pseudomonas?

Well...CAP Guideline does promote empiric use of Carbapenem in the healthcare related CAP ie Nursing home pts..... don't they?
 
Advertisement - Members don't see this ad
Well...CAP Guideline does promote empiric use of Carbapenem in the healthcare related CAP ie Nursing home pts..... don't they?

Guidelines recommend a lot of things as viable options I suppose; which is why everyone in my class during third year had our pretend VAP patient on meropenem, gentamicin and linezolid.
 
But would you think Johnson & Johnson: Ortho McNeil investing hundreds of million dollars to just let the drug sit in the arsenal waiting to be used? The miniskirts will get shorter, heels will get taller, reps will get younger and lunches will get tastier.. and the drug will get promoted like there is no tomorrow. And the cost of healthcare at our expense will again rise.

Exactly...so, until then, keep it off. Wear a blind-fold when the girls walk in, and keep your mouth shut when the filet mignon passes by. We'll see if the pseudomonas superiority claims are true clinically...if the MIC #'s are right, it'll be nice for hospital's dealing with resistance issues.
 
Exactly...so, until then, keep it off. Wear a blind-fold when the girls walk in, and keep your mouth shut when the filet mignon passes by. We'll see if the pseudomonas superiority claims are true clinically...if the MIC #'s are right, it'll be nice for hospital's dealing with resistance issues.

Hospitals that are currently having resistance issues with carbapenems are going to need more than doripenem..
 
Guidelines recommend a lot of things as viable options I suppose; which is why everyone in my class during third year had our pretend VAP patient on meropenem, gentamicin and linezolid.

Well, both CAP and HAP guidelines have penems on the list... it will depend on each hospital to choose the right agent to put on the list.
 
Exactly...so, until then, keep it off. Wear a blind-fold when the girls walk in, and keep your mouth shut when the filet mignon passes by. We'll see if the pseudomonas superiority claims are true clinically...if the MIC #'s are right, it'll be nice for hospital's dealing with resistance issues.

Pseudomonas aren't as big of a concern ....

We're concerned with resistant Acinetobacters, Kleb Pneumo..with ESBL..

I'm not big on filet..
 
Advertisement - Members don't see this ad